Prognostic significance of baseline peripheral blood lymphocyte subsets on second-line immunotherapy in advanced esophageal squamous cell carcinoma

Asian J Surg. 2023 Aug;46(8):3358-3361. doi: 10.1016/j.asjsur.2023.03.082. Epub 2023 Apr 1.

Authors

Qike Wang¹, Xiaona Meng¹, Xu Sun¹, Huaimin Liu²

Affiliations

¹ Department of Integrated Chinese and Western Medicine, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
² Department of Integrated Chinese and Western Medicine, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China. Electronic address: huaiminliu@sina.com.

PMID: 37005184
DOI: 10.1016/j.asjsur.2023.03.082

No abstract available

Keywords: Esophageal squamous carcinoma; Immunotherapy; Peripheral blood lymphocyte subsets; Prognosis.

Publication types

Letter

MeSH terms

Esophageal Neoplasms* / pathology
Esophageal Neoplasms* / therapy
Esophageal Squamous Cell Carcinoma* / therapy
Humans
Immunotherapy
Lymphocyte Subsets / pathology
Prognosis
Retrospective Studies